About the Event
HIE is a devastating condition that affects babies when they’re deprived of oxygen during childbirth. Nobody knows more about the condition than Betsy Pilon, Executive Director of Hope for HIE, an organization that serves thousands of parents worldwide.
ReAlta Life Sciences has developed a new treatment for HIE that has proved so promising in clinical trials it has been awarded Ophan Drug, Fast Track, and Rare Pediatric Disease Designations by the FDA.
Join our webinar to hear from Ms. Pilon and ReAlta CEO, Dr. Ulrich Thienel as they discuss how this treatment can save lives and prevent lifelong disabilities in newborn infants.